Submitted by Anonymous (not verified) on 20 November 2023 - 14:44
Human medicines European public assessment report (EPAR): Tepmetko, tepotinib, Carcinoma, Non-Small-Cell Lung, Date of authorisation: 16/02/2022, Revision: 2, Status: Authorised
Source: